Indication
Skin and skin structure Pseudomonas aeruginosa infection
A skin and skin structure *Pseudomonas aeruginosa* infection is an opportunistic bacterial infection of the cutaneous and underlying subcutaneous tissues caused by the Gram-negative pathogen *Pseudomonas aeruginosa*. Read more about Skin and skin structure Pseudomonas aeruginosa infection
142 drugs 79 manufacturers
Drugs that treat it
Common Skin and skin structure Pseudomonas aeruginosa infection therapies.
CIPROFLOXACIN (ciprofloxacin HCl)
CIPROFLOXACIN (ciprofloxacin HCl)
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA skin and skin structure *Pseudomonas aeruginosa* infection is an opportunistic bacterial infection of the cutaneous and underlying subcutaneous tissues caused by the Gram-negative pathogen *Pseudomonas aeruginosa*.
The condition predominantly affects hospitalized, immunocompromised, or diabetic patients, as well as individuals with compromised epidermal integrity from severe burns, surgical incisions, trauma, or chronic ulcers.
Clinically and pathophysiologically, it can range from localized folliculitis to invasive, necrotizing tissue destruction and gangrenous lesions, such as ecthyma gangrenosum.
Virulence is driven by extracellular enzymes, exotoxins, and biofilm formation, often producing hallmark blue-green pyocyanin pigmentation, a sweet grape-like odor, and a substantial propensity for antimicrobial resistance.
- nih.gov
A skin and skin structure *Pseudomonas aeruginosa* infection is an opportunistic bacterial infection of the cutaneous and underlying subcutaneous tissues caused by the Gram-negative pathogen *Pseudomonas aeruginosa* Clinically and pathophysiologically, it can range from localized folliculitis to invasive, necrotizing tissue destruction and gangrenous lesions, such as ecthyma gangrenosum Virulence is driven by extracellular enzymes, exotoxins, and biofilm formation, often producing hallmark blue-...
- nih.gov
A skin and skin structure *Pseudomonas aeruginosa* infection is an opportunistic bacterial infection of the cutaneous and underlying subcutaneous tissues caused by the Gram-negative pathogen *Pseudomonas aeruginosa* Virulence is driven by extracellular enzymes, exotoxins, and biofilm formation, often producing hallmark blue-green pyocyanin pigmentation, a sweet grape-like odor, and a substantial propensity for antimicrobial resistance
- nih.gov
The condition predominantly affects hospitalized, immunocompromised, or diabetic patients, as well as individuals with compromised epidermal integrity from severe burns, surgical incisions, trauma, or chronic ulcers Virulence is driven by extracellular enzymes, exotoxins, and biofilm formation, often producing hallmark blue-green pyocyanin pigmentation, a sweet grape-like odor, and a substantial propensity for antimicrobial resistance
- cdc.gov
The condition predominantly affects hospitalized, immunocompromised, or diabetic patients, as well as individuals with compromised epidermal integrity from severe burns, surgical incisions, trauma, or chronic ulcers
- webmd.com
The condition predominantly affects hospitalized, immunocompromised, or diabetic patients, as well as individuals with compromised epidermal integrity from severe burns, surgical incisions, trauma, or chronic ulcers
- nih.gov
Clinically and pathophysiologically, it can range from localized folliculitis to invasive, necrotizing tissue destruction and gangrenous lesions, such as ecthyma gangrenosum
- nih.gov
Virulence is driven by extracellular enzymes, exotoxins, and biofilm formation, often producing hallmark blue-green pyocyanin pigmentation, a sweet grape-like odor, and a substantial propensity for antimicrobial resistance
Personalize your experience
Follow Skin and skin structure Pseudomonas aeruginosa infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.